| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 5, Issue 6 575-583, Copyright © 1994 by American Association of Cancer Research
ARTICLES |
BW Woolcock, BM Schmidt, KD Kallman and JR Vielkind
Department of Cancer Endocrinology, B.C. Cancer Agency, Vancouver, Canada.
Pigment (macromelanophore) patterns in the platyfish Xiphophorus maculatus are due to a complex pigmentary locus; for example, the spotted-dorsal (Sd) fin pattern is due to the Sd locus. In interspecific backcross hybrids with the swordtail X. helleri, the Sd pattern changes into benign or malignant dorsal fin melanoma as a result of hemi- or homozygous loss of a platyfish regulatory (R) gene, the tumor suppressor gene Diff, that appears to play a role in the final differentiation of macromelanophores. Closely linked to the pigmentary locus is an epidermal growth factor receptor-like gene, Xmrk-2, that has arisen by duplication from the linked Xmrk-1. The transcriptional expression of the Xmrk genes was determined in various tissues including Sd pigment patterns and melanomas of various growth potential using reverse transcription-polymerase chain reaction. While Xmrk-1 expression was found in all tissues examined, Xmrk-2 expression correlated with pigment cell growth. Xmrk-2 was highly expressed in the dorsal fin exhibiting the Sd pattern but drastically reduced in a platyfish mutant which has lost the capacity to form these pigment cells in the dorsal fin. Most interestingly, Xmrk-2 expression increased with the proliferative capacity of the melanomas but declined once melanoma growth ceased. We conclude that Xmrk-2 plays a role in the formation of the pigment pattern cell type, perhaps in proliferation of precursor cells, which, in melanoma, are kept in a proliferative state due to loss of Diff.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
S. Kazianis, L. D. Coletta, D. C. Morizot, D. A. Johnston, E. A. Osterndorff, and R. S. Nairn Overexpression of a fish CDKN2 gene in a hereditary melanoma model Carcinogenesis, April 1, 2000; 21(4): 599 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schartl, U. Hornung, H. Gutbrod, J.-N. Volff, and J. Wittbrodt Melanoma Loss-of-Function Mutants in Xiphophorus Caused by Xmrk-Oncogene Deletion and Gene Disruption by a Transposable Element Genetics, November 1, 1999; 153(3): 1385 - 1394. [Abstract] [Full Text] |
||||
![]() |
S. Weis and M. Schartl The Macromelanophore Locus and the Melanoma Oncogene Xmrk Are Separate Genetic Entities in the Genome of Xiphophorus Genetics, August 1, 1998; 149(4): 1909 - 1920. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Baudler, J. Duschl, C. Winkler, M. Schartl, and J. Altschmied Activation of Transcription of the Melanoma Inducing Xmrk Oncogene by a GC Box Element J. Biol. Chem., January 3, 1997; 272(1): 131 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Nairn, S. Kazianis, B. B. McEntire, L. Della Coletta, R. B. Walter, and D. C. Morizot A CDKN2-like polymorphism in Xiphophorus LG V is associated with UV-B-induced melanoma formation in platyfish-swordtail hybrids PNAS, November 12, 1996; 93(23): 13042 - 13047. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Kazianis, D C Morizot, B B McEntire, R S Nairn, and R L Borowsky Genetic mapping in Xiphophorus hybrid fish: assignment of 43 AP-PCR/RAPD and isozyme markers to multipoint linkage groups. Genome Res., April 1, 1996; 6(4): 280 - 289. [Abstract] [PDF] |
||||
![]() |
D Fornzler, J Altschmied, I Nanda, R Kolb, M Baudler, M Schmid, and M Schartl The Xmrk oncogene promoter is derived from a novel amplified locus of unusual organization. Genome Res., February 1, 1996; 6(2): 102 - 113. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |